Evidence map›Paper›PMID 40392422›Full record

ArticleBrain tumor pathology2025

Rapidly progressive scalp and lung metastases with fatal pneumothorax in glioblastoma, IDH-wildtype, with MET and CDK6 amplifications: a case report of clinical course and postmortem autopsy, including genetic analysis.

Yoshihiro Tsukamoto, Manabu Natsumeda, Hiroshi Shimizu, Haruhiko Takahashi, Satoshi Shibuma, Asuka Ueno, Akihiro Takahashi, Kazuki Shida, Taiki Saito, Hidemoto Fujiwara and 10 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Brain tumor pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Yoshihiro TsukamotoDepartment of Neurosurgery, Brain Research Institute, Niigata University, 1-757 Asahimachi-Dori, Chu-ou-ku, Niigata, 951-8585, Japan. yoshi.tsukamoto@me.com.ORCID http://orcid.org/0000-0002-2311-5367
Manabu NatsumedaDepartment of Neurosurgery, Brain Research Institute, Niigata University, 1-757 Asahimachi-Dori, Chu-ou-ku, Niigata, 951-8585, Japan.
Hiroshi ShimizuDepartment of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
Haruhiko TakahashiDepartment of Neurosurgery, Brain Research Institute, Niigata University, 1-757 Asahimachi-Dori, Chu-ou-ku, Niigata, 951-8585, Japan.
Satoshi ShibumaDepartment of Neurosurgery, Brain Research Institute, Niigata University, 1-757 Asahimachi-Dori, Chu-ou-ku, Niigata, 951-8585, Japan.
Asuka UenoDepartment of Neurosurgery, Brain Research Institute, Niigata University, 1-757 Asahimachi-Dori, Chu-ou-ku, Niigata, 951-8585, Japan.
Akihiro TakahashiDepartment of Neurosurgery, Brain Research Institute, Niigata University, 1-757 Asahimachi-Dori, Chu-ou-ku, Niigata, 951-8585, Japan.
Kazuki ShidaDepartment of Neurosurgery, Brain Research Institute, Niigata University, 1-757 Asahimachi-Dori, Chu-ou-ku, Niigata, 951-8585, Japan.
Taiki SaitoDepartment of Neurosurgery, Brain Research Institute, Niigata University, 1-757 Asahimachi-Dori, Chu-ou-ku, Niigata, 951-8585, Japan.
Hidemoto FujiwaraDepartment of Neurosurgery, Brain Research Institute, Niigata University, 1-757 Asahimachi-Dori, Chu-ou-ku, Niigata, 951-8585, Japan.
Yoko NakayamaDepartment of Neurosurgery, Brain Research Institute, Niigata University, 1-757 Asahimachi-Dori, Chu-ou-ku, Niigata, 951-8585, Japan.
Yuki TakahashiDepartment of Respiratory Medicine and Infectious Diseases, School of Medical and Dental Sciences, Niigata University Graduate, Niigata University, Niigata, Japan.
Rie KondoDepartment of Respiratory Medicine and Infectious Diseases, School of Medical and Dental Sciences, Niigata University Graduate, Niigata University, Niigata, Japan.
Rie SaitoDepartment of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
Takeyoshi EdaDivision of Pharmacy, Medical and Dental Hospital, Niigata University, Niigata, Japan.
Masayasu OkadaDepartment of Neurosurgery, Brain Research Institute, Niigata University, 1-757 Asahimachi-Dori, Chu-ou-ku, Niigata, 951-8585, Japan.
Kouichirou OkamotoDepartment of Neurosurgery, Brain Research Institute, Niigata University, 1-757 Asahimachi-Dori, Chu-ou-ku, Niigata, 951-8585, Japan.
Toshiaki KikuchiDepartment of Respiratory Medicine and Infectious Diseases, School of Medical and Dental Sciences, Niigata University Graduate, Niigata University, Niigata, Japan.
Akiyoshi KakitaDepartment of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
Makoto OishiDepartment of Neurosurgery, Brain Research Institute, Niigata University, 1-757 Asahimachi-Dori, Chu-ou-ku, Niigata, 951-8585, Japan.

Funding

Japan Society for the Promotion of Science 22K16679
6 · The paper itself

Abstract

We report a rare case of extracranial metastases of a glioblastoma, IDH-wildtype, in a 77-year-old man who initially presented with a right frontal tumor, and gross total resection and adjuvant chemoradiotherapy were performed. The tumor was histologically comprised of two cellular components: astrocytic and poorly differentiated astrocytic tumor cells, with each strongly and infrequently positive for glial markers. Importantly, both components were positive for Nestin and CD44, indicating stemness and migratory characteristics. Three-and-a-half months after surgery, the patient presented with a subcutaneous tumor of the scalp at the surgical site and dyspnea. Imaging studies revealed tumors in the scalp, multiple intracranial locations, and the lungs, complicating a pneumothorax. He died of respiratory failure approximately 4.5 months after tumor resection. An autopsy revealed extra-axial tumors involving the sub/epidural, scalp, and intrathoracic regions, each consisting of tumor cells resembling those of the poorly differentiated astrocytic component observed in the original right frontal tumor. Genetic and copy number analysis proved that the extra-axial tumors were metastatic lesions originating from the right frontal glioblastoma, as MET and CDK6 amplification and TERT promoter mutation were shared in all tumors. These genomic alterations and stemness might contribute to the rapid development of extracranial glioblastoma metastasis and a worse prognosis.

Indexed as

Brain NeoplasmsCyclin-Dependent Kinase 6GlioblastomaLung NeoplasmsPneumothoraxSkin NeoplasmsAgedAutopsyFatal OutcomeGene AmplificationHumansIsocitrate DehydrogenaseMaleScalpTelomeraseCDK6 protein, humanCyclin-Dependent Kinase 6Isocitrate DehydrogenaseTelomeraseTERT protein, humanCDK6Extracranial metastasisGlioblastomaLungMETPneumothoraxStemness

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.